Newsletters have become central for readers of scientific journals. Currently, they are the primary vehicle for spreading newly published articles. With this in mind, we have completely renewed Rev Esp Cardiol newsletters as follows: a) the content is separated according to the language of the articles, with English at the top of the newsletter and Spanish at the bottom; thus, readers can directly access their preferred language; b) articles are classified and grouped according to their specific field, identified by a section heading; c) a central illustration is included for each original, review and special article; d) the number of listed authors per article has been reduced to two (first and last) to avoid a wordy presentation; and e) the header Rev Esp Cardiol is now more visible.

The first revamped newsletter was sent to our subscribers on April 26, 2022. The initial feedback was fairly positive as per the number of articles downloaded, with a significant and sustained increase.

Many journals have now introduced a central illustration in original articles. The goal is to show the main result of the study in a graphic and appealing design. Rev Esp Cardiol joined this trend in 2022, presenting central illustrations in the newsletter and website. We hope our readers find this initiative attractive.

Authors appreciate speed between acceptance of their articles and their availability in Medline. In addition, knowledge is disseminated to the scientific community earlier. So far, the first format through which Rev Esp Cardiol articles could be accessed via Medline was the ahead-of-print publication of the English version. The production of an ahead-of-print article takes around 40 days. Despite the efforts of our editorial office and publisher, we were unable to shorten this production time and so we took the initiative of producing an uncorrected version of our articles (pre-proof) immediately after their acceptance. Overall, this format makes articles available approximately 17 days after acceptance on the Rev Esp Cardiol website and ScienceDirect and about 14 days later on Medline. This does not apply to articles submitted in Spanish, since Medline only indexes the English edition of Rev Esp Cardiol. Consequently, articles submitted in Spanish must wait for their English translation for publication on Medline.

A central objective of scientific journals should be education, which should not be overshadowed by bibliometric interests. Indeed, we have continued and increased the publication of reviews and consensus documents considered of interest to the cardiology community3–13 and the official reports of the national registries of pacemakers,14 implantable automatic defibrillators,15 heart transplant,16 cardiac catheterization and interventional cardiology,17 and catheter ablation.18 Starting this year, the translated version of the ESC guidelines will be available on the SEC website rather than in Rev Esp Cardiol.

The editorial team believes that it is essential to involve young cardiologists in research. To this end, we created 2 new awards for the best articles published in Rev Esp Cardiol by a cardiologist of 40 years or younger and a resident in addition to the annual SEC awards for the best published articles (Table 3). Likewise, at the 2022 SEC Congress held in Palma de Mallorca, the editors delivered a seminar on designing and conducting a research project and writing a scientific article. In addition, in 2022 Rev Esp Cardiol published the best clinical case of the 2022 SEC Clinical Case League in the form of a scientific letter, accompanied by an editorial comment emphasizing its educational value.39,40Rev Esp Cardiol is now preparing the 2023 edition. We hope that all these initiatives will increae awareness among young cardiologists and residents of the importance of research.

Our website is an undisputed reference for information on cardiology in Spanish.41 In 2022, our digital edition was consulted by more than 5.7 million users, with a total of almost 13 million page views. In ScienceDirect, Rev Esp Cardiol articles exceeded 1 million visits to our Spanish and English articles. There were also the views and downloads from other repositories. Most of the traffic comes from the prominent positioning of our articles in search engines (91.4% organic traffic), followed by direct searches and links from other websites.

During the last year, we have been intensely active on social media, mainly on Twitter, the preferred social platform of cardiologists worldwide. The number of followers of the REC Publications Twitter profile42 has increased (20 380 at the beginning of 2023), and efforts have been made to tag article authors, who now also have the possibility of including their Twitter account information in their articles. Last year, we incorporated the creation of threads and increased our multimedia content, with central illustrations to make the articles more attractive to read and enhance their dissemination. We would like to thank the REC Publications’ ICT consultant, Juan Quiles, for his excellent work.

Starting in 2023, there have been some notable innovations regarding the Editor's videos: they have been shortened to 2minutes and, instead of the previous author-editor interview, one of the authors now takes on the leading role, directly presenting the main findings of the research article. Our idea is to facilitate views on mobile devices and social media and optimize the integration of these materials in CardioTV, the audiovisual SEC ecosystem. Rev Esp Cardiol will continue the regular publication of author interviews on the Rev Esp Cardiol Blog,43 on the SEC website and their presence in SEC News and other SEC bulletins.

Registries are an essential source of research activity. They often involve multiple centers and patients. Consequently, coordination and data management require considerable effort by principal investigators and these articles deserve publication of the results in a top journal like Rev Esp Cardiol. For this purpose, proper design and high-quality data are essential. In a recent Editor's page, we expressed concerns about self-reported, unaudited registries submitted to Rev Esp Cardiol.44 In summary, our thoughts are as follows: a) a registry should address not only what is already known in a particular context but also some novel features; b) the availability of electronic clinical histories allows homogeneity of data acquisition among centers, in terms of a reproducible flowchart for screening and recruitment, and facilitates follow-up.45 Therefore, the final article should present a flowchart and the completeness of the follow-up. Furthermore, these articles will now have to include information on participating centers, listing the principal investigator in each center who is responsible for the accuracy of the data.